FR941202-0-00035 FR941202-0-00001 §35.615 Safety precautions. * * * * * (d) *␣*␣* (3) A radiation monitor must be checked with a dedicated check source for proper operation each day before the teletherapy unit is used for treatment of patients or human research subjects. * * * * * (e) A licensee shall construct or equip each teletherapy room to permit continuous observation of the patient or the human research subject from the teletherapy unit console during irradiation. 42. In §35.900, paragraphs (a)(4) and (a)(5) are revised and paragraphs (a)(6) through (a)(9) are added to read as follows: §35.900 Radiation Safety Officer. * * * * * (a) *␣*␣* (4) American Board of Science in Nuclear Medicine; (5) Board of Pharmaceutical Specialties in Nuclear Pharmacy; (6) American Board of Medical Physics in radiation oncology physics; (7) Royal College of Physicians and Surgeons of Canada in nuclear medicine; (8) American Osteopathic Board of Radiology; or (9) American Osteopathic Board of Nuclear Medicine; or * * * * * 43. In §35.910, paragraph (a)(3) is revised, paragraphs (a)(4) and (a)(5) are added, and paragraphs (b)(2)(i), (b)(2)(iii), and (b)(2)(v) are revised to read as follows: §35.910 Training for uptake, dilution, and excretion studies. * * * * * (a) *␣*␣* (3) Diagnostic radiology or radiology by the American Osteopathic Board of Radiology; (4) Nuclear medicine by the Royal College of Physicians and Surgeons of Canada; or (5) American Osteopathic Board of Nuclear Medicine in nuclear medicine; or (b) *␣*␣* (2) *␣*␣* (i) Examining patients or human research subjects and reviewing their case histories to determine their suitability for radioisotope diagnosis, limitations, or contraindications; * * * * * (iii) Administering dosages to patients or human research subjects and using syringe radiation shields; * * * * * (v) Patient or human research subject followup; or * * * * * 44. In §35.920, paragraphs (a)(2) and (a)(3) are revised, paragraphs (a)(4) and (a)(5) are added, and paragraphs (b)(2)(iii), (b)(3)(i), (b)(3)(iii), and (b)(3)(v) are revised to read as follows: §35.920 Training for imaging and localization studies. * * * * * (a) *␣*␣* (2) Diagnostic radiology by the American Board of Radiology; (3) Diagnostic radiology or radiology by the American Osteopathic Board of Radiology; (4) Nuclear medicine by the Royal College of Physicians and Surgeons of Canada; or (5) American Osteopathic Board of Nuclear Medicine in nuclear medicine; or (b) *␣*␣* (2) *␣*␣* (iii) Calculating and safely preparing patient or human research subject dosages; * * * * * (3) *␣*␣* (i) Examining patients or human research subjects and reviewing their case histories to determine their suitability for radioisotope diagnosis, limitations, or contraindications; * * * * * (iii) Administering dosages to patients or human research subjects and using syringe radiation shields;
